Validation of TearLab Osmometer - Human Factor Usability Report
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
California
-
San Diego, California, United States, 92130
- Gordon Binder Weiss Vision Institute
-
-
Kentucky
-
Louisville, Kentucky, United States, 40202
- Kentucky Lion Eye Center, University of Louisville
-
-
Ohio
-
Columbus, Ohio, United States, 43210
- The Ohio State University College of Optometry
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Healthy volunteers representing the general population (a minimum of 120 subjects representing 50% of the total study population,
- Otherwise healthy volunteers previously-diagnosed with moderate or severe chronic dry eye and/or Sjogrens syndrome and/or designated as dry eye disease subjects by the OSDI questionnaire (a minimum of 40 subjects representing 50% of the total study population),
- Men or women,
- Adult 18 years or older,
- Contact lens wearers may participate,
- Patients having undergone refractive surgery may participate,
- Patients having undergone cataract surgery may participate
Exclusion Criteria:
- Eye pathology other than previously-diagnosed moderate or severe chronic dry eye and/or Sjogrens syndrome, Use of topical medication within the last 24 hours,
- Eye drop usage within the last 2 hours,
- Ocular surface staining within the last 2 hours,
- Other invasive ocular diagnostic testing within the last 2 hours,
- Crying within the last 30 minutes,
- Eye makeup present on the eye lid within 10 minutes of tear collection,
- Examination by slit lamp within 10 minutes of tear collection.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Volunteer Patients/Subjects
These subjects should present the general population.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Tear Osmolarity in Human Measured by TearLab System
Time Frame: Single visit, at time of tear osmolarity testing.
|
Tear osmolarity was measured with a laboratory-on-a-chip, which simultaneously collects and analyzes the electrical impedance of a 50 nL tear sample from the inferior lateral meniscus (TearLab Osmolarity System).
The results are reported in mOsm/L.
The trial was not set up to evaluate diagnostic performance, as no gold-standard method was used to establish dry eye status, but rather, to determine whether the TearLab could measure tear osmolarity in human subjects.
|
Single visit, at time of tear osmolarity testing.
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Michael A Lemp, MD, Clinical Professor of Ophthalmology, Georgetown University
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- TP00004
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.